Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4738-4745
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4738
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4738
Figure 2 Pancreatic ductal adenocarcinoma and low grade neuroendocrine tumor components.
A: Pancreatic ductal adenocarcinoma component in low power (40 ×); B: Pancreatic ductal adenocarcinoma component in high power (400 ×); C and D: Intermingled pancreatic ductal adenocarcinoma (yellow arrow) and well-differentiated neuroendocrine tumor (blue arrow), hematoxylin and eosin (H&E, 200 × and 400 ×); E: Lymph node with metastatic ductal adenocarcinoma (H&E, 200 ×, yellow arrow); F: Lymph node with well-differentiated neuroendocrine tumor (H&E, 200 ×, blue arrow).
- Citation: Zhao X, Bocker Edmonston T, Miick R, Joneja U. Mixed pancreatic ductal adenocarcinoma and well-differentiated neuroendocrine tumor: A case report. World J Gastrointest Oncol 2024; 16(12): 4738-4745
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4738.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4738